Endoscopic metal stents for the palliation of malignant upper gastroduodenal obstruction
- PMID: 22234067
- DOI: 10.5754/hge10310
Endoscopic metal stents for the palliation of malignant upper gastroduodenal obstruction
Abstract
Background/aims: Gastric outlet obstruction (GOO) is frequently caused by tumor. Recently, endoscopic implantation of self-expanding metallic stents (SEMS) has been introduced as an improved palliative treatment for GOO. This study aims to study the effect of SEMS placement on nutrient intake in patients with GOO and correlate different SEMS positions with postoperative clinical outcomes.
Methodology: Fifty six non-operable patients with GOO were enrolled. Obstruction of the duodenum (n=23) or gastric outlet (n=33) were commonly found. Either Wallstent Enteral Stents, WallFlex Enteral Duodenal or partially covered Ultraflex esophageal stents were placed under endoscopic and fluoroscopic guidance. The Gastric Outlet Obstruction Score (GOOSS) was used as the main outcome measurement.
Results: The procedure was technically feasible in 100% of patients and gave satisfactory clinical results in 98.2% (55/56). The patients had a median survival time of 97.5 days (range 9-380). Median stent patency was 72 days with a range of 8 to 267 days. The average GOOSS, measuring oral intake, was significantly improved, regardless of obstruction site (p<0.05). We also found that the site of SEMS placement did not affect the clinical outcome.
Conclusions: Palliation with SEMS is a safe and effective method for restoring gastric intake in patients with malignant GOO.
Similar articles
-
Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study.Gastrointest Endosc. 2009 May;69(6):1059-66. doi: 10.1016/j.gie.2008.07.026. Epub 2009 Jan 18. Gastrointest Endosc. 2009. PMID: 19152912
-
First data on the palliative treatment of patients with malignant gastric outlet obstruction using the WallFlex enteral stent: a retrospective multicenter study.Endoscopy. 2007 May;39(5):434-9. doi: 10.1055/s-2007-966338. Endoscopy. 2007. PMID: 17516350
-
Endoscopic stenting in patients with recurrent malignant obstruction after gastric surgery: uncovered versus simultaneously deployed uncovered and covered (double) self-expandable metal stents.Gastrointest Endosc. 2007 May;65(6):782-7. doi: 10.1016/j.gie.2006.08.030. Epub 2007 Feb 26. Gastrointest Endosc. 2007. PMID: 17324410
-
Oral intake throughout the patients' lives after palliative metallic stent placement for malignant gastroduodenal obstruction: a retrospective multicentre study.Eur J Gastroenterol Hepatol. 2012 Jul;24(7):747-55. doi: 10.1097/MEG.0b013e328353d9d3. Eur J Gastroenterol Hepatol. 2012. PMID: 22522142 Review.
-
Self-expandable metallic stents for malignant gastric outlet obstruction.Adv Ther. 2010 Oct;27(10):691-703. doi: 10.1007/s12325-010-0061-2. Epub 2010 Aug 19. Adv Ther. 2010. PMID: 20737260 Review.
Cited by
-
The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers.Int J Clin Oncol. 2014 Aug;19(4):629-33. doi: 10.1007/s10147-013-0613-y. Epub 2013 Sep 3. Int J Clin Oncol. 2014. PMID: 23999903
-
Stent implantation technique through PEG-like pathway for treatment of malignant gastroduodenal obstruction.Int J Clin Exp Med. 2015 Aug 15;8(8):14236-41. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26550402 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical